Asthma: Tezepelumab Reduced Annual Exacerbations
Tezepelumab reduced annual exacerbations in patients with severe, uncontrolled asthma regardless of their use of additional controller medications.
Tezepelumab reduced annual exacerbations in patients with severe, uncontrolled asthma regardless of their use of additional controller medications.